Furthermore, GLI inhibitors effectively suppress cancer growth in many GLI-dependent cancers that utilize an SMO-independent route of GLI regulation, of which treatment with upstream inhibitors has proven ineffective [17]. The gene discussed is GLI1; the disease is cancer.